Sunday, April 10, 2005 3:01:02 PM
..."Does Beth Isreal think that DNAP is the best choice to finish the development and then market their drug?"
That would be the logical conclusion, and I doubt looking for other discrediting reasons very practical, unless surmising for/or submitting missing info, in depreciation be your part to play.
Hey, just my thoughts, and imho, and would be ginning on a gurney if I had to take the journey.
Easy
Peace, Blessings & Boat Drinks, Easy
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM